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Synthesis of Fmoc-Ser-(O-beta-D-galactose-pentaacetate)-OH
For the synthesis and characterization of this compound, please refer to our previous publication.
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Synthesis and purification of Fmoc-Ser-(O-beta-D-glucose-pentaacetate)-OH
The synthesis of Fmoc-Ser-(O-β-D-glucose-pentaacetate)-OH was carried out by dissolving β-Dglucose-pentaacetate (4 mmol) (Sigma, 285943) and vacuum-dried Fmoc-Ser-OH (1.2 eq.) (Iris Biotech, FAA1578 ) in dry acetonitrile (20 mL). The solution was placed on ice and BF 3 -Et 2 O (1 eq.) was added. The mixture was then left to slowly warm up to room temperature. An additional equivalent of BF 3 -Et 2 O was added after both 6 and 15 hours of stirring. After 20 hours, the reaction was shown by TLC to be complete and the mixture was diluted with DCM (30 mL) and sequentially washed with a 1 M HCl (3 x 30 mL) and H 2 O (2 x 30 mL). The organic phase was dried with MgSO 4 and the solvents were removed under reduced pressure. The crude product was purified by RP-HPLC using a gradient of 40%-100% MeOH in H 2 O to obtain 2.5 mmol Hz, Ar). The crude product (pale yellow) was concentrated and purified by silica gel column chromatography (2:1 Hex:EtOAc) to yield 1.8 mmol (69%) of the glycosylated intermediate. between each conjugate and the respective Glc-functionalized control peptide using unpaired Student's t test (*p<0.05, **p<0.01, ***p<0.005).
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Fluorescence microscopy Figure S7 . Fluorescence microscopy images of HepG2 cells after 30 minutes incubation of 0.4 uM 2Gal-S 3/10 (A); 2Glc-0 3/10 (B); 3Gal-S 3/10-17 (C); 3Glc-0 3/10/17 (D).
